Skip to main content
. 2018 Oct 9;19(4):1470320318803495. doi: 10.1177/1470320318803495

Figure 4.

Figure 4.

Subgroup analysis of cardiovascular outcomes between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.